Galatea Bio's mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics.
Galatea Bio has raised $8.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
Galatea Bio's investors include Founder Collective, F-Prime Capital, Digitalis Ventures, Helios Investment Partners, Alexandria Real Estate Equities.
Galatea Bio is headquartered in Miami Lakes, United States.
Galatea Bio's mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics.
Galatea Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Galatea Bio — Funding & Investors." VCBacked, March 27, 2025, https://www.vcbacked.co/company/galatea-bio. Accessed November 12, 2026.
VCBacked. (2025). Galatea Bio — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/galatea-bio
{{cite web |title=Galatea Bio — Funding & Investors |url=https://www.vcbacked.co/company/galatea-bio |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Galatea Bio? Request a listing update